Time-dependent retention and discontinuation of eslicarbazepine acetate treatment in real-world focal epilepsy: The first three months as a key period.
PURPOSE Eslicarbazepine acetate (ESL) is a widely used anti-seizure medication (ASM), used as monotherapy or adjunctive therapy for patients with focal epilepsy, including drug-resistant epilepsy. Detailed analyses of factors associated with treatment outcomes are limited; therefore, this study evaluated 12-month reten...